Advanced company searchLink opens in new window

SQN CLINICAL LIMITED

Company number 06926512

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 Oct 2024 GAZ1(A) First Gazette notice for voluntary strike-off
23 Sep 2024 DS01 Application to strike the company off the register
25 Jun 2024 CS01 Confirmation statement made on 6 June 2024 with no updates
10 Jan 2024 AA Accounts for a small company made up to 31 December 2022
12 Jul 2023 SH19 Statement of capital on 12 July 2023
  • GBP 1,000
11 Jul 2023 SH20 Statement by Directors
11 Jul 2023 CAP-SS Solvency Statement dated 11/07/23
11 Jul 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 11/07/2023
13 Jun 2023 CS01 Confirmation statement made on 6 June 2023 with no updates
07 Jan 2023 AA Accounts for a small company made up to 31 December 2021
21 Jun 2022 CS01 Confirmation statement made on 6 June 2022 with no updates
07 Feb 2022 AD01 Registered office address changed from Faiers House Gilray Road Diss IP22 4WR to 27 Old Gloucester Street London WC1N 3AX on 7 February 2022
02 Nov 2021 AP01 Appointment of Cynthia Henderson as a director on 29 October 2021
02 Nov 2021 TM01 Termination of appointment of Kenneth Jason Cash as a director on 29 October 2021
07 Oct 2021 AA Accounts for a dormant company made up to 31 December 2020
17 Jun 2021 CS01 Confirmation statement made on 6 June 2021 with updates
15 Mar 2021 PSC02 Notification of Veristat International Limited as a person with significant control on 18 February 2021
15 Mar 2021 PSC07 Cessation of Brian John Pring as a person with significant control on 18 February 2021
15 Mar 2021 PSC07 Cessation of Karen Michelle Grover as a person with significant control on 18 February 2021
15 Mar 2021 AP01 Appointment of Patrick Flanagan as a director on 18 February 2021
15 Mar 2021 AP01 Appointment of Kenneth Jason Cash as a director on 18 February 2021
15 Mar 2021 TM01 Termination of appointment of Karen Michelle Grover as a director on 18 February 2021
04 Feb 2021 PSC04 Change of details for Mr Brian John Fring as a person with significant control on 22 January 2021
04 Feb 2021 MR04 Satisfaction of charge 1 in full
02 Feb 2021 PSC04 Change of details for Mrs Karen Michelle Grover as a person with significant control on 22 January 2021